Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 5.83M | $600.0M | 9.31% | +279.5K | 2026-06-30 |
| Artisan Partners Limited Partnership | 4.80M | $494.0M | 7.66% | -1.57M | 2026-06-30 |
| FMR LLC | 4.70M | $483.0M | 7.50% | +2.81M | 2026-06-30 |
| ARK Investment Management LLC | 4.55M | $468.0M | 7.26% | -1.79M | 2026-06-30 |
| Price T Rowe Associates Inc | 3.63M | $373.0M | 5.80% | +3.56M | 2026-06-30 |
| State Street Corp | 3.23M | $332.0M | 5.16% | -438.1K | 2026-06-30 |
| Vanguard Portfolio Management LLC | 2.82M | $290.0M | 4.51% | +175.9K | 2026-06-30 |
| Vanguard Capital Management LLC | 2.70M | $277.0M | 4.31% | +60.2K | 2026-06-30 |
| EdgePoint Investment Group Inc. | 2.52M | $259.0M | 4.02% | -2.86M | 2026-06-30 |
| William Blair Investment Management, LLC | 2.17M | $223.0M | 3.47% | -3.10M | 2026-06-30 |
